METROPOLISNSEMetropolis Healthcare LimitedLowNeutral
Announced Thu, 14 Aug · 18:48 IST

Metropolis Healthcare Limited has submitted the Exchange a copy Scrutinizers report of Annual General Meeting held on August 13, 2025

Board & Shareholder Meetings View source PDF

METROPOLIS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Metropolis Healthcare held its 25th AGM on August 13, 2025 via video conferencing, with shareholders voting on 11 resolutions. A total of 4,74,80,700 votes were polled, representing 91.65% of outstanding shares. All 11 resolutions were passed, including adoption of FY25 audited financial statements (99.9998% in favor), re-appointment of Mr. Hemant Sachdev and Ms. Ameera Shah as directors (96.92% and 99.73% in favor respectively), re-appointment of Ms. Ameera Shah as Chairperson & Whole-time Director (99.77% in favor), ratification of cost auditors Joshi Apte & Associates (99.9997% in favor), and appointment of Manish Ghia & Associates as new secretarial auditors (99.9997% in favor). Shareholders also approved the new Metropolis ESOP 2025 and Restrictive Stock Units Plan 2025 (97.05% and 99.23% in favor respectively), including their extension to subsidiary employees.

Likely market impact

All key business and governance items were cleared by shareholders, providing stability to the board and management. Notably, the resolution to approve Dr. Sushil Shah's remuneration saw meaningful dissent at 13.22% (28.52% from institutional investors), which investors should watch as a potential governance flag. The approval of ESOP and RSU plans could lead to future equity dilution once grants are made.